Clinical Trial Update: Apatinib as Second-line Treatment of Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase 2 trial of apatinib as second-line treatment for advanced pancreatic cancer. The current trial status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Pancreatic Neoplasms | Phase 2 | Status: UNKNOWN